Carmine N. Stengone sold $160K of Contineum Therapeutics, Inc. (CTNM) stock

Carmine N. Stengone, CEO and President of Contineum Therapeutics, Inc. (CTNM), sold 10,000 shares of CTNM stock worth $160K, per an SEC Form 4 filed Jul 1, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 30, 2026, 1 day before it was made public.

CTNM has moved -17.3% since the trade date, from $16.39 to $13.55 (Sep 21, 2026 close).